不同宫颈预处理方案在绝经后宫腔镜手术患者术前预处理中的应用效果

doi:10.3969/j.issn.1671-7171.2026.04.017

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1145 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the efficacy effects of different cervical pretreatment methods in the preoperative preparation of postmenopausal patients undergoing hysteroscopic surgery. 【Methods】 A total of 120 postmenopausal patients who underwent hysteroscopic surgery in our hospital from January 2023 to December 2024 were selected and randomly divided into group A, group B, and group C, with 40 cases in each group. Group A was pretreated with a disposable cervical dilator 60 minutes before the operation, group B was intravenously injected with 80 mg phloroglucinol 30 minutes before the operation, and group C was placed with 400 μg misoprostol in the posterior vaginal fornix 12 hours before the operation. The total effective rate of cervical softening, dilation time, and the incidence of adverse reactions were compared among the three groups. 【Results】 The total effective rate of cervical softening in group A and group B was significantly higher than that in group C (P<0.05), however, there was no significant difference between group A and group B (P>0.05). The cervical dilation time in group A and group B was significantly shorter than that in group C (P<0.05), but there was no significant difference between group A and group B (P>0.05). The total incidence of adverse reactions in group A and group B was significantly lower than that in group C (P<0.05), however, there was no significant difference between group A and group B (P>0.05). 【Conclusion】 In the preoperative preparation of postmenopausal patients undergoing hysteroscopic surgery, both the disposable cervical dilator and phloroglucinol can effectively soften the cervix, shorten the dilation time, and have a low incidence of adverse reactions, with better effects than misoprostol. They can be considered as preferred clinical options.

Key words： Hysteroscopy Postmenopause Cervix Uteri

Received: 12 September 2025

PACS:

R711.74

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CUI Haitao
	LI Rui
	HE Xiaoli

Cite this article:

CUI Haitao,LI Rui,HE Xiaoli. Application of Different Cervical Pretreatment Methods in Preoperative Preparation of Postmenopausal Patients Undergoing Hysteroscopy Surgery[J]. JOURNAL OF CLINICAL RESEARCH, 2026, 43(4): 588-590.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2026.04.017 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2026/V43/I4/588

[1] 段倩,张培珍. 绝经后激素分泌改变引起脂代谢异常及运动干预对脂代谢异常调节的研究进展[J].中国全科医学,2023,26(12):1536-1542.
[2] FAGIOLI R, VITAGLIANO A, CARUGNO J, et al. Hysteroscopy in postmenopause: from diagnosis to the management of intrauterine pathologies[J].Climacteric,2020, 23(4):360-368.
[3] 梁靓.宫腔镜诊断育龄期女性慢性子宫内膜炎的研究进展[J].中国微创外科杂志,2022,22(12):975-979.
[4] 吴浩,张雪颖,陈讯,等. 宫腔镜下子宫内膜形态学在子宫内膜癌诊断中的应用研究进展[J].医学综述,2021,27(23):4736-4740.
[5] 措毛吉,才德吉,万玛南杰,等. 独参汤结合米索前列醇对产后宫缩乏力性出血凝血功能和子宫复旧状况的影响[J].中华中医药学刊,2024,42(7):214-217.
[6] 杨怡珂,于之恒,顾珣可,等. 孕晚期口服小剂量米索前列醇溶液促宫颈成熟的有效性与安全性[J].中华围产医学杂志,2024,27(1):24-32.
[7] 刘美华,彭黎群,钟瑱. 联用马来酸麦角新碱与卡前列甲酯栓在防治宫缩乏力性产后出血中的应用效果[J].中国医学创新,2024,21(21):57-60.
[8] 张多多,赵毅飞,申乐,等. 人工流产术前缩短卡前列甲酯给药时间对软化子宫颈效果和围术期安全性影响随机对照研究[J].中国实用妇科与产科杂志,2024,40(3):349-353.
[9] 翟瑶,张静,张姗姗,等. 间苯三酚在无痛人工流产中软化宫颈作用的研究[J].中国妇幼健康研究,2021,32(1):97-101.
[10] 尹君,于君,刘娟蓉. 一次性导尿管联合间苯三酚在宫腔镜术前宫颈预处理的临床效果[J].中国综合临床,2020,36(6):544-547.
[11] VITALE S G. Hysteroscopic management of intrauterine pathologies in postmenopause[J].Climacteric,2020, 23(4): 319-320.
[12] 嵇玉芹,刘海燕. 间苯三酚对绝经后患者宫腔镜术前宫颈软化的有效性和安全性[J].中国计划生育学杂志,2025,33(3):568-571.
[13] 施锦金,张晶,何晶. 间苯三酚对比地西泮对初产妇分娩效果的临床研究[J].中国药师,2024,27(7):1178-1183.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2026, 43(3): 453-455.